ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Fennec Pharmaceuticals Inc

Fennec Pharmaceuticals Inc (FENC)

8,70
-0,46
(-5,02%)
Fermé 07 Juin 10:00PM
8,69
-0,01
(-0,11%)
Après les heures de négociation: 1:59AM

Fennec Pharmaceuticals Inc (FENC) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
8,70
( -5,02% )
Prix Achat
5,43
Prix Vente
12,25
Volume échangé
169 994
8,57 Fourchette du Jour 9,14
5,65 Plage de 52 semaines 10,45
Cap du marché
Clôture Veille
9,16
Ouverture
9,14
Dernière Transaction
1387
@
8.7
(priorref)
Dernière heure de transaction
Volume financier
US$ 1 489 020
VWAP
8,7592
Volume moyen (3 m)
US$ 248 483
Actions en circulation
34 737 030
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-35,89
Bénéfice par action (BPA)
-0,27
Chiffre d'affairess (LTM)
51M
Bénéfice net (LTM)
-8,38M

À propos de Fennec Pharmaceuticals Inc

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company’s product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regio... Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company’s product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Siège social
Research Triangle Park, United States
Fondé
1996
Fennec Pharmaceuticals Inc est coté dans le secteur Healthcare de la NASDAQ avec le ticker FENC. Le dernier cours de clôture d'Fennec Pharmaceuticals était de US$9,16. Au cours de la dernière année, les actions de Fennec Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 5,65 à US$ 10,45.

Fennec Pharmaceuticals compte actuellement 34 737 030 actions en circulation. La capitalisation boursière d'Fennec Pharmaceuticals est de US$302,21 million. Fennec Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -35.89.

FENC Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-1.24-12.47484909469.9410.18.693137169.7201829CS
41.7625.36023054766.9410.456.754142669.40699757CS
121.0213.281257.6810.455.652592068.04982648CS
260.9512.25806451617.7510.455.651942317.97718129CS
521.0714.02359108787.6310.455.651418418.12122464CS
1560.435.199516324068.2711.923.961205547.827714CS
2601.2616.9354838717.4411.923.82191096657.65720364CS

FENC - Frequently Asked Questions (FAQ)

What is the current Fennec Pharmaceuticals Inc share price?
The current share price of Fennec Pharmaceuticals Inc is US$ 8,70
How many Fennec Pharmaceuticals Inc shares are in issue?
Fennec Pharmaceuticals Inc has 34 737 030 shares in issue
What is the market cap of Fennec Pharmaceuticals Inc?
The market capitalisation of Fennec Pharmaceuticals Inc is USD 302,21M
What is the 1 year trading range for Fennec Pharmaceuticals Inc share price?
Fennec Pharmaceuticals Inc has traded in the range of US$ 5,65 to US$ 10,45 during the past year
What is the PE ratio of Fennec Pharmaceuticals Inc?
The price to earnings ratio of Fennec Pharmaceuticals Inc is -35,89
What is the cash to sales ratio of Fennec Pharmaceuticals Inc?
The cash to sales ratio of Fennec Pharmaceuticals Inc is 6,76
What is the registered address of Fennec Pharmaceuticals Inc?
The registered address for Fennec Pharmaceuticals Inc is 68 TW Alexander Drive, Research Triangle Park, North Carolina, 27709
What is the Fennec Pharmaceuticals Inc website address?
The website address for Fennec Pharmaceuticals Inc is www.fennecpharma.com
Which industry sector does Fennec Pharmaceuticals Inc operate in?
Fennec Pharmaceuticals Inc operates in the Biotechnology & Life Sciences sector

FENC Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion